• Skip to primary navigation
  • Skip to main content
  • Skip to footer
  • English
MotherToBaby

MotherToBaby

Medications and More during pregnancy and breastfeeding

Hide Search
Show Search
866.626.6847
  • About
    • Our Work
    • Our Team
    • Our Partners
  • Exposures
    • Pregnancy & Breastfeeding Exposures
    • Fact Sheets
    • Baby Blogs
    • Podcasts
  • Studies
    • Ongoing Studies
    • Pregnant Women
    • Join Now
    • Health Providers
    • Pharma Industry
    • Publications
  • Health Professionals
    • Patient Education and Provider Resources
    • Refer a Patient
    • Request Materials
    • Meetings
    • FAQs
    • OTIS Membership
  • Media
    • Press Releases
    • Media Requests
  • In Your Area
  • OTIS
    • About OTIS
    • OTIS Membership
    • Annual Meeting
    • Member Log-In
    • Donate
  • Contact

Rheumatology

Managing Rheumatoid Conditions During Pregnancy & Lactation

MotherToBaby supports rheumatologists in managing rheumatoid diseases during pregnancy and while breastfeeding. We understand the challenges that you face when deciding on treatment courses when your patient is pregnant or breastfeeding. Care of pregnant and lactating women with serious conditions like rheumatoid arthritis (RA), spondyloarthritis, or lupus is further complicated by the physiological changes of pregnancy that may alter symptoms, severity, or treatment needs. Our resources will help you weigh the risks and benefits to both mom and baby as you determine a treatment plan that maximizes disease management and minimizes maternal and fetal/infant risk. 

We are also dedicated to furthering the information and understanding of medication safety in pregnancy through our observational MotherToBaby Pregnancy Studies. We are proud to lead more than half of all Food and Drug Administration (FDA)-mandated pregnancy registries conducted in the U.S., including studies on RA, JIA, psoriatic arthritis, and ankylosing spondylitis treatments. MotherToBaby Pregnancy Studies are rigorously designed cohort studies that aim to provide critically needed product safety information – and your patient referrals make all the difference. With your referral, you are helping us generate data that will lead to improved product safety information in pregnancy, thereby providing you and your patients with the evidence you need to make more informed treatment decisions.

As treatment for rheumatic diseases improves, more women with these illnesses are willing and able to start a family. This adds complexity to our treatment of young women with lupus, rheumatoid arthritis, and other diseases. We must now address contraception, pregnancy planning, and medication risks early with our patients in order to optimize pregnancy success.

— Mitchell et al., 2010

Explore how we can help you and your pregnant and breastfeeding patients by providing no-cost exposure risk assessments, patient education materials, observational studies to monitor pregnancy outcomes, and more.

Related Studies

  • Actemra® (tocilizumab)
  • Ankylosing Spondylitis
  • Arava® (leflunomide)
  • Cimzia® (certolizumab pegol)
  • Coronavirus (COVID-19)
  • Giant Cell Arteritis
  • Juvenile Idiopathic Arthritis
  • Kevzara® (sarilumab)
  • Otezla® (apremilast)
  • Psoriatic Arthritis
  • Rheumatoid Arthritis
  • Tremfya® (guselkumab)
  • Xeljanz® (tofacitinib citrate)

Related Fact Sheets

  • Abatacept (Orencia®)
  • Adalimumab (Humira®)
  • Ankylosing Spondylitis
  • Apremilast (Otezla®)
  • Azathioprine | 6-mercaptopurine
  • Belimumab (Benlysta®)
  • Certolizumab Pegol (Cimzia®)
  • Etanercept (Enbrel®)
  • Hydroxychloroquine
  • Leflunomide (Arava®)
  • Lupus
  • Methotrexate
  • Prednisone | Prednisolone
  • Psoriasis and Psoriatic Arthritis
  • Rheumatoid Arthritis
  • Sarilumab (Kevzara®)
  • Tocilizumab (Actemra®)
  • Tofacitinib (Xeljanz®, Xeljanz XR®)
  • Ustekinumab (Stelara®)

Exposure Information

We provide no-cost, evidence-based info on exposures during pregnancy or breastfeeding by phone, text, email, and chat.

Contact

Request Materials

We offer free patient education materials and provider resources for our information service and pregnancy studies.

ORDER

Partners

  • Canadian Arthritis Patient Alliance
  • Creaky Joints
  • MyHealthTeams
  • Patient Education Genius
  • PatientsLikeMe
  • Society for Maternal-Fetal Medicine
  • Society for Birth Defects Research & Prevention
  • Spondylitis Association of America
  • The Mighty

FAQs

Get answers to the most frequently asked questions about our information service and pregnancy studies.

Read

Stay In Touch

Our e-Newsletter brings you the latest information, news, and resources from the experts at MotherToBaby.

Sign Up

Refer a Patient

Need to give your patient a personalized assessment on an exposure risk or connect her to our pregnancy studies?

refer

Footer

           

Hot Links

  • Home
  • Exposures
  • Fact Sheets
  • Baby Blogs
  • Podcasts
  • Pregnancy Studies
  • Join a Study Now
  • Healthcare Professionals
  • Refer a Patient
  • Request Materials
  • News
  • Donate
  • Ask An Expert

Current Studies

  • Ankylosing Spondylitis
  • Asthma
  • Coronavirus (COVID-19)
  • Crohn’s Disease
  • Eczema (Moderate-to-Severe)/Atopic Dermatitis
  • Juvenile Idiopathic Arthritis
  • Multiple Sclerosis
  • Pertussis/Tdap vaccine (“Whopping Cough” vaccine)
  • Psoriasis
  • Psoriatic Arthritis
  • Rheumatoid Arthritis
  • Ulcerative Colitis

Contact

Exposure Information Service
866.626.6847

Pregnancy Studies
877.311.8972

Media Inquiries
615.349.3082
contactus@mothertobaby.org

MotherToBaby, a service of the Organization of Teratology Information Specialists
OTIS Logo

OTIS National Office
5034A Thoroughbred Lane
Brentwood, TN 37027

Copyright © 2021 The Organization of Teratology Information Specialists

  • Accessibility
  • Privacy
  • Terms
  • Site Map
^